🚨Exciting news from our clinical team! 🚨 We have findings from a qualitative study in collaboration with Stanford Healthcare AI Applied Research Team (HEA3RT). The study explored a topic we know customers and partners care a lot about … integrating primary and virtual care. By teaming up with healthcare providers, we're digging into the potential, challenges, and possibilities of virtual care. Check out a recent Proof Points to learn more about our findings: https://lnkd.in/eRa_6BHy
🚨New Analysis on GLP-1 Discontinuation from Omada Health🚨 A new real-world analysis shows that Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6-7% weight gain estimated from trial data. Carolyn Bradner Jasik, MD states, “These findings show that members who are better supported throughout their journey can be more successful post-discontinuation when GLP-1s are paired with lifestyle change programs like Omada.” Learn more: https://lnkd.in/dviYtTUa
💡Did you know that 76 % of Omada for Diabetes members have met our A1C reduction goals in the program? 💡 Through proactive support and science-backed intervention, Omada can close gaps in care to help members manage their diabetes for improved long-term results. Want to learn more about the Omada for Diabetes program? Check it out: https://lnkd.in/eHT7m6vi
🚨New Analysis on GLP-1 Discontinuation from Omada Health🚨 A new real-world analysis shows that Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6-7% weight gain estimated from trial data. Carolyn Bradner Jasik, MD states, “These findings show that members who are better supported throughout their journey can be more successful post-discontinuation when GLP-1s are paired with lifestyle change programs like Omada.” Learn more: https://lnkd.in/dviYtTUa
🚨 New findings from Omada Health on GLP-1s for weight loss 🚨 The latest insights from our ANSWERS initiative was published recently, analyzing members taking GLP-1s for weight loss. The top findings? 🤝 Members taking GLP-1s wanted support and took advantage of a companion program 🏃 A GLP-1 focused program can affect health behavior 💡 A specifically designed program can build belief and self-efficacy 💪 Members in a GLP-1 program experienced early indicators of healthy weight loss Want to learn more? Read the white paper: https://lnkd.in/dUB8U8Te
🚨Exciting news from our clinical team! 🚨 We have findings from a qualitative study in collaboration with Stanford Healthcare AI Applied Research Team (HEA3RT). The study explored a topic we know customers and partners care a lot about … integrating primary and virtual care. By teaming up with healthcare providers, we're digging into the potential, challenges, and possibilities of virtual care. Check out a recent Proof Points to learn more about our findings: https://lnkd.in/eRa_6BHy
Omada recently partnered with a PBM to explore the real-world impact of GLP-1s alongside behavior change programs and how this collaboration can improve outcomes. So what did we find? Relationship-oriented engagement matters for GLP-1 users. That engagement could mean interacting with a care team, or social support from topic-based communities, like the one we created for GLP-1 users. Since last year, about 4k members have joined our medications for weight loss community! Want to know more about how social support influences outcomes for GLP-1 users? Check out the Proof Points on this topic penned by Jennifer Becker and Michael Kahn Read it here: https://lnkd.in/eHGvUamy
Research shows that diabetes and cardiometabolic conditions, such as hypertension, are some of the top clinical concerns from employers. So what options are they choosing to help? According to Truist Securities, Omada is a top choice for employers considering digital diabetes, hypertension, and weight management programs. We’d like to think it’s because we’re delivering what benefit buyers want: ❗An engaging benefit that people will use ❗Clinically validated care and improved outcomes ❗Savings - because of the squeeze that cardiometabolic disease can have on their budgets. Interested in learning more? Check out our latest report on how we measure value: https://lnkd.in/d6dk4QFj
Our very own Nancy Vitale took some time with the folks at Built by People to speak about Omada's Employee Value Proposition (EVP) and the importance of aligning EVP with company mission, vision, and values. Check it out now on Spotify!
🚀 Omada Health is doubling down on our promise to complete, not compete with primary care. Our new research with Stanford Healthcare AI Applied Research Team (HEA3RT) is inspiring. Findings include: 👩⚕️ Majority of providers believe there’s a role for virtual care programs 🤝 76% of providers expressed confidence in recommending virtual care programs 📈 82% are likely to use biometric data from outside sources, like virtual care programs We're in it to enrich patient care, alongside the providers who provide in-person care. Ready for a deep dive? ↪️ Read the findings here: https://lnkd.in/dd6MjeqR
